U.S. markets closed

Pacific Biosciences of California, Inc. (PACB)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
32.13+1.92 (+6.36%)
At close: 4:00PM EDT
31.55 -0.58 (-1.81%)
After hours: 05:31PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 8/4/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) 1.12
52-Week Change 3670.66%
S&P500 52-Week Change 332.92%
52 Week High 353.69
52 Week Low 33.90
50-Day Moving Average 330.98
200-Day Moving Average 331.71

Share Statistics

Avg Vol (3 month) 32.35M
Avg Vol (10 day) 32.28M
Shares Outstanding 5199.01M
Implied Shares Outstanding 6N/A
Float 186.83M
% Held by Insiders 16.80%
% Held by Institutions 183.45%
Shares Short (Jul 14, 2021) 412.23M
Short Ratio (Jul 14, 2021) 46
Short % of Float (Jul 14, 2021) 47.95%
Short % of Shares Outstanding (Jul 14, 2021) 46.15%
Shares Short (prior month Jun 14, 2021) 413.77M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Mar 30, 2021


Profit Margin -64.25%
Operating Margin (ttm)-114.19%

Management Effectiveness

Return on Assets (ttm)-8.85%
Return on Equity (ttm)-34.78%

Income Statement

Revenue (ttm)92.29M
Revenue Per Share (ttm)0.53
Quarterly Revenue Growth (yoy)85.90%
Gross Profit (ttm)32.57M
EBITDA -99.01M
Net Income Avi to Common (ttm)-59.29M
Diluted EPS (ttm)-0.34
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.16B
Total Cash Per Share (mrq)5.85
Total Debt (mrq)936.61M
Total Debt/Equity (mrq)333.84
Current Ratio (mrq)35.45
Book Value Per Share (mrq)1.41

Cash Flow Statement

Operating Cash Flow (ttm)-78.96M
Levered Free Cash Flow (ttm)-142.65M